glp-1 and eating disorder Agonist for Binge Disorder: Evidence Safety GLP-1 Drugs and Eating Disorders:

European Medicines Agency (2024) EMA statement on ongoing review of GLP-1 receptor agonists

This blog post aims to provide a fully informed, science-based perspective on what to expect regarding nausea and vomiting with Wegovywhy these symptoms occur, how common and severe they are, and practical strategies to manage them

Probiotics and Antimicrobial Proteins

After four hours, a breath alcohol content below .02 percent, and the study physicians approval, the participant was OKd to leave

Pharmacokinetics and brain distribution of the therapeutic peptide liraglutide by a novel LCMS/MS analysis

The intestinal microbiota fuelling metabolic inflammation